Degradation behavior of theophylline/chitosan/β-cyclodextrin microspheres for pulmonary drug delivery

Authors

  • Li Wang Affiliated Reproductive Medicine Center, Weifang Medical University, Weifang 261042, Shandong
  • Tingting Yang Department of Pharmaceutics, College of Pharmacy, Weifang Medical University, Weifang 261053
  • Weiping Ju Department of Neurology, Wendeng Central Hospital of Weihai, Affiliated Hospital of Weifang Medical University, Wendeng 266400, Shandong
  • Ming Ren Affiliated Hospital of Weifang Medical University, Weifang 261053
  • Zhanqin Feng Department of Pharmaceutics, College of Pharmacy, Weifang Medical University, Weifang 261053
  • Zengjuan Zheng Department of Pharmaceutics, College of Pharmacy, Weifang Medical University, Weifang 261053
  • Zhenbo Hu Affiliated Hospital of Weifang Medical University, Weifang 261053
  • Yuqing Liu Department of Pathology, College of Basic Medicine, Weifang Medical University, Weifang 261053
  • Weifen Zhang Department of Pharmaceutics, College of Pharmacy, Weifang Medical University, Weifang 261053

DOI:

https://doi.org/10.3329/bjp.v11iS1.25634

Keywords:

Chitosan, ?-Cyclodextrin, Pulmonary drug delivery, Theophylline

Abstract

To evaluate the degradation behavior of theophylline/chitosan/β-cyclodextrin microspheres, we performed both in vitro study by putting the microspheres in phosphate buffered saline or in phosphate buffer saline with enzyme and in vivo study by implanting the microspheres into the back of male Sprague-Dawley rats. The results showed that microspheres were degraded in enzymatic hydrolysis and phosphate buffer saline, which were degraded faster in 0.2 mg/mL lysozyme than in phosphate buffer saline. The morphology of microspheres in phosphate buffer saline and enzyme solution developed rough surfaces, and showed irregular shape and pores after 8 weeks. The microspheres were degraded in vivo within 8 weeks with irregular, sheet, porous morphology, and the diameters were smaller than 5 ?m. These results indicated that the theophylline/chitosan/β-cyclodextrin microspheres had a good degradation both in vitro and in vivo which can be used as a pulmonary drug delivery carrier.

Downloads

Download data is not yet available.
Abstract
1689
Download
1094 Read
635

Downloads

Additional Files

Published

2016-03-06

How to Cite

Wang, L., T. Yang, W. Ju, M. Ren, Z. Feng, Z. Zheng, Z. Hu, Y. Liu, and W. Zhang. “Degradation Behavior of theophylline/Chitosan/β-Cyclodextrin Microspheres for Pulmonary Drug Delivery”. Bangladesh Journal of Pharmacology, vol. 11, no. S1, Mar. 2016, pp. S116-S122, doi:10.3329/bjp.v11iS1.25634.

Issue

Vol. 11 (2016): Special Issue

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).